WPG Advisers’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
WPG Advisers's AMED Position: Q3 2025 in Review
WPG Advisers sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3 shares — an estimated $295 sold.
WPG Advisers first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $556 in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- WPG Advisers reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- WPG Advisers sold 3 Amedisys shares in Q3 2025, an estimated $295.
- WPG Advisers first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
- WPG Advisers's Amedisys position peaked at $556 in Q1 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on WPG Advisers's 13F filing for Q3 2025, filed 29 Oct 2025.